11 results match your criteria: "Center of Excellence for asthma[Affiliation]"
BMJ Open
December 2024
School of Medicine, Universidad Internacional del Ecuador, Quito, Pichincha, Ecuador
Objective: This study explored the attributes of asthma care coordination from the perspective of healthcare professionals at different levels of care in Ecuador.
Design: Qualitative descriptive study. The Integrated Health Networks Model was the theoretical framework of reference.
Allergy
November 2024
Department of Pulmonary Diseases, Center of Excellence for Asthma, COPD and Respiratory Allergy, Franciscus Gasthuis and Vlietland, Rotterdam, Netherlands.
BMC Pulm Med
April 2024
Department of Pulmonary Diseases, Center of Excellence for asthma, COPD and respiratory allergy, Franciscus Gasthuis & Vlietland, P.O. box 3045 PM, Rotterdam, The Netherlands.
Background: Asthma is a common disease characterized by chronic inflammation of the lower airways, bronchial hyperactivity, and (reversible) airway obstruction. The Global Initiative of Asthma Guideline recommends a flowchart to diagnose asthma with first-step spirometry with reversibility and a bronchial challenge test (BPT) with histamine or methacholine as a second step [1]. The BPT is considered burdensome, time-consuming for patients and staff, can cause side effects, and is expensive.
View Article and Find Full Text PDFRespir Res
November 2023
Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands.
Introduction: Interstitial lung disease (ILD) may be difficult to distinguish from other respiratory diseases due to overlapping clinical presentation. Recognition of ILD is often late, causing delay which has been associated with worse clinical outcome. Electronic nose (eNose) sensor technology profiles volatile organic compounds in exhaled breath and has potential to detect ILD non-invasively.
View Article and Find Full Text PDFJ Asthma
October 2023
Department of Pulmonary Medicine, STZ Center of Excellence for Asthma and COPD, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Introduction: Severe asthma is associated with a serious disease burden, partially caused by limitations in activity and work impairment.
Aims And Objectives: This study aims to relate treatment with biologics targeting IL-5/5Ra to work productivity and activity in the long term in a real-world context.
Material And Methods: This is a registry-based multi-center cohort study evaluating data from adults with severe eosinophilic asthma included in the Dutch Register of Adult Patients with Severe Asthma for Optimal DIsease management (RAPSODI).
Clin Transl Allergy
December 2021
Department of Pulmonary Medicine, STZ Center of Excellence for Asthma and COPD, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
NPJ Prim Care Respir Med
October 2020
Department of Respiratory Medicine, STZ Center of Excellence for Asthma, COPD and Respiratory Allergy, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Many asthmatics in primary care have mild symptoms and lack airflow obstruction. If variable expiratory airflow limitation cannot be determined by spirometry or peak expiratory flow, despite a history of respiratory symptoms, a positive bronchial challenge test (BCT) can confirm the diagnosis of asthma. However, BCT is traditionally performed in secondary care.
View Article and Find Full Text PDFJ Allergy Clin Immunol
October 2017
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Division of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Background: The structural changes of the respiratory system related to ageing determine lung function decline in healthy subjects after 25 years of age. An annual reduction of 25 ml in Forced Expiratory Volume in 1 s (FEV1) is expected. We aimed to describe the longitudinal lung function variation of subjects with severe asthma receiving appropriate treatment.
View Article and Find Full Text PDFLancet Respir Med
May 2016
University of Groningen, Department of Respiratory Medicine, Amsterdam, Academic Medical Centre, University of Amsterdam, Netherlands.
Int J Chron Obstruct Pulmon Dis
September 2016
Department of Pulmonary Diseases, STZ Center of Excellence for Asthma & COPD, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
Background: Traditional assessment of patients with obstructive lung diseases (asthma and chronic obstructive pulmonary disease; COPD) relies on physiological tests. The COPD and Asthma Rotterdam Integrated Care Approach (CORONA) study aims to develop a diagnostic pathway with a more comprehensive approach to the assessment of patients with asthma and COPD in secondary care.
Methods: An eight-step method was used to develop and implement the pathway for patients with asthma or COPD referred to an outpatient hospital setting.